Alzheimer’s disease risk prediction from clinical and social determinants of health: a machine learning cohort study in UK Biobank - Summary - MDSpire

Alzheimer’s disease risk prediction from clinical and social determinants of health: a machine learning cohort study in UK Biobank

  • By

  • Junming Hu

  • Simon Lu

  • Qi Zhang

  • Kehan Qian

  • Habbiburr Rehman

  • Congcong Zhu

  • John Farrell

  • Julio E Castrillon-Candas

  • Rhoda Au

  • Lindsay A Farrer

  • Wei Q Qiu

  • Jinying Chen

  • Xiaoling Zhang

  • June 1, 2026

  • 0 min

Share

Objective:

To develop and validate a fully automated machine learning pipeline for predicting Alzheimer’s disease (AD) risk using UK Biobank data, specifically integrating social determinants of health (SDOH) with clinical and genetic predictors.

Approach:
    Key Findings:
    • Age and APOE genotype are strong contributors to AD risk.
    • Social determinants of health (SDOH) significantly and independently contribute to AD risk prediction.
    • Routinely collected health and social data can support scalable, low-cost AD risk screening, enhancing the predictive model.
    Interpretation:

    The study emphasizes the integration of SDOH with traditional clinical predictors in AD risk models.

    Limitations:
    • The study's findings may not be generalizable beyond the UK Biobank population, limiting applicability to broader demographics.
    • Potential biases in self-reported data and missing values could affect the results, potentially skewing the risk predictions.
    Conclusion:

    Incorporating SDOH into AD risk prediction models can enhance the accuracy and scalability of screening tools.

Original Source(s)

Alzheimer’s disease risk prediction from clinical and social determinants of health: a machine learning cohort study in UK Biobank

  • by Junming Hu, Simon Lu, Qi Zhang, Kehan Qian, Habbiburr Rehman, Congcong Zhu, John Farrell, Julio E Castrillon-Candas, Rhoda Au, Lindsay A Farrer, Wei Q Qiu, Jinying Chen, Xiaoling Zhang

  • June 1, 2026

Related Content

AETA peptide contributes to Alzheimer’s disease signature of synapse dysfunction

Editorial: Cross-talk of synaptic proteins in neurological diseases

Predictive value of Galectin-3 in cognitive impairment: a systematic review and meta-analysis